Incretin Hormones in Type 1 Diabetes Mellitus;Effect of Metformin Treatment

Summary

Investigators aim is to conduct an RCT to study the effect of adjunct metformin treatment to insulin monotherapy in patients with type 1 diabetes, targeting the intestinal incretin secretion. The patients will be randomly allocated to metformin or placebo treatment for 4 months

Timeline

Start

2019-11-29

Primary completion

2022-11-29

Completion

2022-11-29

Drugs

Indications